The novel virucidal protein cyanovirin-N (CV-N) binds with equally high affinity to soluble forms of either H9 cell-produced or recombinant glycosylated HIV-1 gp120 (sgp120) or gp160 (sgp160). Fluorescence polarization studies showed that CV-N is also capable of binding to the glycosylated ectodomain of the HIV-envelope protein gp41 (sgp41) (as well as SIV glycoprotein 32), albeit with considerably lower affinity than the sgp120/ CV-N interaction. Pretreatment of CV-N with either sgp120 or sgp41 abrogated the neutralizing activity of CV-N against in-tact, infectious HIV-1 virions. Isothermal calorimetry and optical biosensor binding studies showed that CV-N bound to recom-binant sgp120 with a Kd value ranging from 2 to 45 nM and to sgp41 wi...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
Cyanovirin-N (CV-N) is a small, cyanobacterial lectin that neutralizes many enveloped viruses, inclu...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
The human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein gp41 is an important mediator ...
Cyanovirin-N (CV-N), an 11-kDa protein isolated from the cyanobacterium Nostoc ellipsosporum, potent...
Cyanovirin-N (CV-N), an 11-kDa protein isolated from the cyanobacterium Nostoc ellipsosporum, potent...
abstract: Over the past two decades, a significant amount of research has been conducted investigati...
The development of anti-human immunodeficiency vi-rus (HIV) microbicides for either topical or ex vi...
Glycan-targeting antibodies and pseudo-antibodies have been extensively studied for their stoichiome...
Herein we report that the novel HIV-inactivating protein cyano-virin-N (CV-N) targets specific, N-li...
The novel antiviral protein cyanovirin-N (CV-N) was initially discovered based on its potent activit...
Cyanovirin-N (CV-N) is an antiviral lectin with potent activity against enveloped viruses, including...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovirin...
Cyanovirin-N (CV-N) is a small, cyanobacterial lectin that neutralizes many enveloped viruses, inclu...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
Cyanovirin-N (CV-N) is a small, cyanobacterial lectin that neutralizes many enveloped viruses, inclu...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
The human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein gp41 is an important mediator ...
Cyanovirin-N (CV-N), an 11-kDa protein isolated from the cyanobacterium Nostoc ellipsosporum, potent...
Cyanovirin-N (CV-N), an 11-kDa protein isolated from the cyanobacterium Nostoc ellipsosporum, potent...
abstract: Over the past two decades, a significant amount of research has been conducted investigati...
The development of anti-human immunodeficiency vi-rus (HIV) microbicides for either topical or ex vi...
Glycan-targeting antibodies and pseudo-antibodies have been extensively studied for their stoichiome...
Herein we report that the novel HIV-inactivating protein cyano-virin-N (CV-N) targets specific, N-li...
The novel antiviral protein cyanovirin-N (CV-N) was initially discovered based on its potent activit...
Cyanovirin-N (CV-N) is an antiviral lectin with potent activity against enveloped viruses, including...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovirin...
Cyanovirin-N (CV-N) is a small, cyanobacterial lectin that neutralizes many enveloped viruses, inclu...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...
Cyanovirin-N (CV-N) is a small, cyanobacterial lectin that neutralizes many enveloped viruses, inclu...
OBJECTIVE: To explore the feasibility of expressing the potent HIV-inactivating protein, cyanovi...